Navigation Links
has in Biological Technology

SK Life Sciences has Licensed Pristima

Xybion Medical Systems, is pleased to announce that SK Life Science, Inc. (SKLSI), has licensed Pristima for its Research and Development facility in Fair Lawn, New Jersey. Cedar Knolls, NJ (PRWEB) August 3, 2009 -- Xybion Medical Systems, a world leader in toxicology a...

MIT is pleased to announce that it has received a US$ 500,000 private placement from its Chinese partners

DENVER, CO, June 25 /PRNewswire-FirstCall/ - Medical International Technology Inc. (MDLH. PK) ( http://www.mitcanada.ca http://www.mitinvest.ca ), MIT is pleased to announce that it has received a US$ 500,000 private placement from its Chinese partners and a new order of 200 units. This privat...

Wound Management Technologies, Inc. Announced Today That It Has Reached an Agreement in Principal to Acquire BioPharma Management Technologies, Inc.

FORT WORTH, Texas, June 16 /PRNewswire/ -- Wound Care Innovations, LLC, a subsidiary of Wound Management Technologies, Inc., (WNDM.OB), announced today that it has reached an agreement in principle to acquire BioPharma Management Technologies, Inc., a privately held biotechnology company with a pl...

New Phase 3 Data Continue to Indicate that Wyeth's Investigational 13-valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease

COLLEGEVILLE, Pa., June 11 /PRNewswire-FirstCall/ -- New data from Phase 3 European clinical trials reinforce that Wyeth's (NYSE: WYE ) investigational pneumococcal vaccine, Prevenar 13* (Pneumococcal Polysaccharide Conjugate Vaccine, 13-valent [Adsorbed]), has the potential to provide cov...

Techne Corporation Announces That John L. Higgins has Accepted a Seat on Techne's Board

MINNEAPOLIS, May 19 /PRNewswire-FirstCall/ -- Techne Corporation (Nasdaq: TECH ) today announced that Mr. John L. Higgins has accepted a position on Techne's Board of Directors and will also serve as a member of Techne's Audit, Compensation and Nominations and Governance Committees. Mr. Higgins...

The Concerned Shareholders of Biovail Say Biovail Has Misled Shareholders

Shareholders are Urged to Vote their YELLOW proxy, FOR the Election of Two Highly Qualified and Independent Directors to the Biovail Board TORONTO, May 15 /PRNewswire/ - The Concerned Shareholders of Biovail today said that Biovail Corporation (NYSE: BVF ) (TSX:BVF) continues to mi...

Yongye Biotechnology Distributor has Record Breaking Single Store Sales Day

BEIJING, May 1 /PRNewswire-Asia/ -- Yongye Biotechnology International, Inc. (OTC Bulletin Board: YGYB; "Yongye" or the "Company"), a leading distributor of plant and animal nutrient products located in the People's Republic of China, today announced that one of the independently owned Yongye bran...

FDA has Granted HUD (Humanitarian Use Device) Designation to ITGI's Pericardium Covered Stents, Over and Under(R) and Aneugraft(R), for Treatment of Perforations and Dissections of Native Coronary Arteries and Saphenous Vein Grafts

OR AKIVA, Israel, April 28 /PRNewswire-FirstCall/ -- ITGI Medical, Ltd. (TASE: ITGI) a company engaged in research, development, manufacturing and marketing of heterologous tissue covered stents, announced that the US Food and Drug Administration (FDA) has granted HUD (Humanitarian Use Device)...

The NIHR Biomedical Research Centre for Mental Health London has Joined the MetaMiner CNS Partnership Program

ST. JOSEPH, Mich., March 24 /PRNewswire/ -- GeneGo, Inc., the leading systems biology tools company, announced today that the NIHR Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust and King's College London (BRC-MH), has joined the MetaMiner CNS Par...

Monsanto's Historic R&D Investment has Contributed to Mid-20s Gross Profit Growth for Its Seeds and Genomics Segment

Drought-Tolerance Technology Crosses Another Key Regulatory Milestone LONDON, March 10 /PRNewswire-FirstCall/ -- Monsanto's historic investment in research and development in breeding and biotechnology has contributed to a 24 percent compound annual growth rate for the company's Seeds and G...

Bavarian Nordic Has Essentially Agreed a Pathway for the Licensure of IMVAMUNE(R) With the FDA After Successful End of Phase II Meeting

KVISTGAARD, Denmark, March 3 /PRNewswire-FirstCall/ -- Following the completion of the Phase II clinical development of IMVAMUNE(R), a third-generation smallpox vaccine, Bavarian Nordic has held an end of Phase II meeting with the FDA to discuss the Phase III development. The meeting was a suc...

Sigma-Aldrich (NASDAQ:SIAL) Announces it Has Filed Its December 31, 2008 Form 10-K

ST. LOUIS, Feb. 27 /PRNewswire-FirstCall/ -- A copy of the Company's December 31, 2008 Form 10-K, as filed with the Securities & Exchange Commission, may be obtained without charge at our website address, www.sigma-aldrich.com , or upon writing to the Secretary, Sigma-Aldrich Corporation, P. ...

Accidental discovery has potential for new applications in packaging

CLEVELAND A recent discovery at Case Western Reserve University may help keep food and drugs safer and fresher longer and electronic equipment dryer and more secure than ever before all at a lower cost. The finding involves a nanotechnology-based technique to block the transport of damaging g...

Novel Diabetes Drug Discovery Has Potential to Reverse Disease

WYNNEWOOD, Pa., Jan. 27 /PRNewswire/ -- A study released today in Endocrine Practice (2008;14:1075), the leading peer-reviewed journal for practicing endocrinologists in the US and 65 countries, reports a ground breaking discovery with the potential to reverse type 1 and 2 diabetes. Scientists ...

Rising H9N2 Influenza Replikin Count Has Doubled That of H5N1

The H9N2 strain of influenza commonly infects poultry and occasionally humans. Replikins, Ltd., using its FluForecast® software, has studied the Replikin Count® annually in each of H9N2 and its sister strain H5N1. Cyclic increases and decreases appear to be synchronous for H9N2 and H5N1...

NeoStem's New York City Adult Stem Cell Collection Center Has Opened and Begun Collections

NEW YORK, Dec. 4 /PRNewswire-FirstCall/ -- NeoStem, Inc. (NYSE Alternext US: NBS), which is pioneering the pre-disease collection, processing and long-term storage of adult stem cells for future medical need, today announced that it has reached a major milestone in its current business plan with t...

Keryx Biopharmaceuticals Notified that Nasdaq Has Extended Minimum Bid Price Rule Compliance Period

NEW YORK, Oct. 23 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ) announced today that it has received notice from The Nasdaq Stock Market ("Nasdaq") stating that Nasdaq Marketplace Rule 4310(c)(4), which requires companies to maintain a minimum bid price of $1.00 per...

CORD:USE Cord Blood Bank is Proud to Announce that Cord Blood Pioneer and Leading Transplanter Dr. Eliane Gluckman has Joined its Team

ORLANDO, Fla., Oct. 14 /PRNewswire/ -- Dr. Eliane Gluckman, recognized as a pioneer and leader in the field of cord blood stem cell transplantation, has joined the team at CORD:USE Cord Blood Bank. "We are honored to have such an accomplished physician as Dr. Gluckman join our team of highly e...

Arbios Announces It Has Suspended Operations

Action taken to conserve cash while seeking financing/strategic alternatives WALTHAM, Mass., Aug. 5 /PRNewswire-FirstCall/ -- Arbios Systems, Inc. (OTC Bulletin Board: ABOS) announced today that the Company is focusing its day-to-day operations exclusively on o...

Arbel Medical has Completed a $4.5 million Round of Capital Raising led by Giza Venture Capital Fund

YOKNEAM, Israel, July 17 /PRNewswire/ -- Arbel Medical, an Israeli start-up developing the next generation of medical equipment for removing tumors by freezing (cryotherapy), has completed raising $4.5 million of capital in its second round, led by the Giza Venture Capital fund. The Docor In...

World Chemical Industry Has Decided to Gather at ChemOutsourcing Show on September 7-9 in New Jersey

LONG BRANCH, N.J., July 8 /PRNewswire/ -- The world chemical and pharmaceutical industries are slated to gather in New Jersey in early September to attend the Pharma ChemOutsourcing show. The annual fine and custom chemicals sourcing event is geared to top pharmaceutical and chemical leadershi...

Access Pharmaceuticals Presents New Data at International Symposium Showing Company's Angiolix(R) Monoclonal Antibody has Potential to Treat Cancer by Attacking Cancer Stem Cells

DALLAS, June 26 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) announced that the Company gave an oral presentation yesterday on its monoclonal antibody product, Angiolix(R), at the 7th International Congress on Recombinant Antibodies, held in Dublin, Ireland...

Awareness of Genzyme's Renvela(R) (Sevelamer Carbonate) is High, Although Uptake of this New Phosphate Binding Agent has Been Slower than Nephrologists and Renal Dietitians Initially Expected

EXTON, Pa., May 23 /PRNewswire/ -- BioTrends Research Group, Inc. released Wave 1 of its LaunchTrends(TM): Renvela report, the second in a multi-phase syndicated market research project tracking the launch of Renvela from baseline awareness through the first six months of product availability....

Nebulized Formoterol Fumarate Has Comparable Pharmacokinetic and Pharmacodynamic Profile to Dry Powder Formulation

- Data from two clinical trials presented at International ATS Conference - NAPA, Calif., May 20 /PRNewswire/ -- Data presented today at the International Conference of the American Thoracic Society (ATS) demonstrate that Perforomist(TM) Inhalation Solution (formoterol fumarate inhalation soluti...

Avastin Used in Combination with Drugs from Bristol-Myers Squibb Has Advantages in Survival Rates Over the Current Sales-Leading Therapy for Advanced Ovarian Cancer

Avastin Used in Combination with Taxol and Paraplatin Will Become the Clinical Gold Standard Treatment by 2011, According to a New Report from Decision Resources WALTHAM, Mass., April 23 /PRNewswire/ -- Decision Resources, one of the world's leading research and ad...

eBioscience Corporation Announced Today That James Glynn Has Been Appointed to Its Board of Directors, Effective April 15, 2008

SAN DIEGO, April 15 /PRNewswire/ -- Mr. Glynn has over 34 years of combined financial, operating and director level experience, and is well known within the life sciences industry for his role in the growth and development of several biotechnology companies. Most notably, Mr. Glynn retired fro...

Nanosized technology has supersized effect on tumors

Anyone facing chemotherapy would welcome an advance promising to dramatically reduce their dose of these often harsh drugs. Using nanotechnology, researchers at Washington University School of Medicine in St. Louis have taken a step closer to that goal. The researchers focused a powerful drug d...

China Biologic Products Announces One of Its R&D Projects Has Been Listed In National Torch Plan

TAIAN CITY, China, March 25 /Xinhua-PRNewswire-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("CBP," or "the Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that one of its R&D projects, "Hi...

AMEX Notifies Signalife That It Has Accepted Signalife's Plan of Compliance

GREENVILLE, S.C., March 20 /PRNewswire-FirstCall/ -- On January 7, 2008, Signalife received a deficiency letter from the American Stock Exchange ("AMEX") pursuant to which it advised that Signalife would need to comply with the $6 million stockholders' equity threshold required for continued l...

USANA's CEO Myron W. Wentz, Ph.D. Has Been Elected to Serve on Immunosyn Corporation's Board of Directors

LA JOLLA, Calif., March 17 /PRNewswire-FirstCall/ -- Immunosyn Corporation (OTC Bulletin Board: IMYN) is pleased to announce that Myron W. Wentz, Ph.D., Chief Executive Officer and Chairman of the Board of USANA Health Sciences, Incorporated (Nasdaq: USNA ), was elected to serve as a member o...

National Stem Cell Holding, Inc. Has Engaged BMA Securities to Assist and Advise the Company With Its Current Capital Raise of $3,500,000

MOUNTAINSIDE, N.J., Feb. 19 /PRNewswire-FirstCall/ -- National Stem Cell Holding, Inc. (OTC: NHGI) today announced the engagement of Burt Martin Arnold Securities, Inc. ("BMA Securities") to provide advisory and investment banking services with respect to assisting and advising the company wit...

Former Manchester City Lord Mayor Has Hope Restored at New Beike Stem Cell Facility

QINGDAO, China, Feb. 14 /Xinhua-PRNewswire/ -- Shenzhen Beike Biotechnology Co., Ltd. ( http://www.beikebiotech.com ), the world leader in the use of umbilical cord stem cells to successfully treat a variety of illnesses, announced that Audrey Jones, the former Lord Mayor of Manchester, has ...

A researcher of UPV/EHU has designed nanomagnets for industry

The PhD, defended by chemist Sonia Moralejo Garca at the University of the Basque Country (UPV/EHU), achieved a well-defined line for the manufacture of nanomagnets and other magnetic devices of wide industrial application. It is well known that current technology tends to design tools that are...

The Jordan Company, L.P. Has Teamed with the Management of Haas TCM Inc. to Form Haas TCM Group Inc.

NEW YORK, Jan. 11 /PRNewswire/ -- "I am pleased to announce that Haas TCM Inc. and its subsidiaries, Kemfast Aerospace Group, Ltd. and Kemfast, Ltd (collectively Kemfast) and its MC Technologies division have combined with an affiliate of The Jordan Company, L.P. to form Haas TCM Group Inc. IC...

National Stem Cell Holding, Inc. Posts Company and Financial Information on the OTCIQ and Has Retained New CFO and Counsel to File Registration Statement With SEC

MOUNTAINSIDE, N.J., Dec. 17 /PRNewswire-FirstCall/ -- National Stem Cell Holding, Inc. (Other OTC: NHGI) today announced that its company information, financial information, quotations and press releases are posted on the OTCIQ, a service of the Pink Sheets. OTCIQ is a secure, web-based port...

Elbit Medical Imaging Ltd. Announces that Plaza Centers Has Entered into a Joint Venture Partnership to Develop Residential and Office Projects in Romania

TEL-AVIV, Oct. 23 /PRNewswire-FirstCall/ -- Elbit Medical Imaging Ltd. (TASE, Nasdaq: EMITF) ("EMI" or the "Company") announced today that its subsidiary, Plaza Centers N.V. (LSE: PLAZ) ("Plaza"), a leading Central and Eastern European ("CEE") and in India emerging markets property developer, ...

Agendia BV Announces That its Chief Research Officer Laura van 't Veer has Received a 2007 Breast Cancer Research Foundation Award

AMSTERDAM, The Netherlands, October 22 /PRNewswire/ -- Agendia BV, a world leader in the rapidly evolving field of cancer molecular diagnostics, announced today that its Chief Research Officer Laura van 't Veer has received a prestigious 2007 Breast Cancer Research Foundation Award from the Pi...

SALVAT has Completed Patient Enrollment in a Dose Finding Phase II Trial of SVT-40776 for the Treatment of Overactive Bladder

Results Expected to be Delivered by November 2007 BARCELONA, Spain, October 9 /PRNewswire/ -- This double-blind, placebo-controlled and multi-center Phase II trial includes 332 patients with Overactive Bladder (OAB) and has been conducted at 77 sites in 11 countries (US, Germany, Sp...

European Union has 'Three-Speed' Healthcare System - Many Countries Lagging in Reform

BRUSSELS, October 1 /PRNewswire/ -- Austria now has the most consumer-friendly healthcare system in Europe, according to the 2007 Euro Health Consumer Index (EHCI). The EHCI compares all the EU 27 national healthcare systems, along with Norway and Switzerland, from a consumer-friendly point of...

ThalesNano Inc. Opens Own Representation in the United Kingdom and has New Distribution Agreements for Europe and India

BUDAPEST, Hungary, September 24 /PRNewswire/ -- ThalesNano Inc., a leading developer and manufacturer of flow chemistry, flow reactor technology, and hydrogenation technology solutions, announced today that it had continued to expand globally by opening a subsidiary in the United Kingdom and b...
Other Tags
(Date:8/20/2014)... honeybees grows to about 4,000 members, it triggers an ... of a special type of comb used for rearing ... the Department of Neurobiology and Behaviour at Cornell University, ... cycle of honeybee colonies. The results are published in ... . , Reproduction isn,t always a honeybee colony,s ...
(Date:8/20/2014)... POINT ROBERTS, Washington , August 20, 2014 /PRNewswire/ ... in Addressing Security Concerns in the Payment Industry?   ... covering leading sectors including biometrics, issues commentary from analysts and ... Jason Peaslee , Managing Partner at Thrive Analytics, Isabelle ... , CEO of NXT-ID, Inc. (OTCBB: NXTD) ( OTCQB:NXTD ), ...
(Date:8/19/2014)... 19, 2014 To improve students, chances of ... the University of Houston (UH) implemented a comprehensive ... at risk for failure. , Through a ... (THECB), the Department of Biology and Biochemistry embarked ... taking "General Biology" for non-majors and "Introductory Biology" ...
Breaking Biology News(10 mins):Worker bees 'know' when to invest in their reproductive future 2Digital Wallets for a Digital World - the Players and the Concerns for Consumer Adoption 2Digital Wallets for a Digital World - the Players and the Concerns for Consumer Adoption 3Digital Wallets for a Digital World - the Players and the Concerns for Consumer Adoption 4Digital Wallets for a Digital World - the Players and the Concerns for Consumer Adoption 5Digital Wallets for a Digital World - the Players and the Concerns for Consumer Adoption 6Digital Wallets for a Digital World - the Players and the Concerns for Consumer Adoption 7University of Houson program earns kudos for improving grades, retaining students 2University of Houson program earns kudos for improving grades, retaining students 3
(Date:8/21/2014)... Relias Learning, the leader in SaaS-based training and ... announced the latest release of its flagship LMS with ... , “Supporting the Tin Can API ensures our ... learning capabilities and the ability to leverage the latest ... Jim Triandiflou, CEO of Relias Learning. “To provide our ...
(Date:8/21/2014)... ERT, a leading global ... efficacy endpoint data collection, today opened registration ... Maximizing Product Value with Optimized Endpoints. ... biopharmaceutical developers to network with leading researchers ... developing, implementing, and justifying effective strategies for ...
(Date:8/21/2014)... elicited by T-type calcium channels in the thalamic ... of calcium. These channels enable thalamic reticular nucleus ... to enter a hyper-excited state. , In order ... absence seizures, the researchers conducted an experiment to ... techniques to delete the T-type calcium channel CaV3.3. ...
(Date:8/21/2014)... we put on in the morning? Do we drive to ... we want to buy lunch? We make hundreds of different ... minimal impact, it is extremely important for our long-term personal ... People with ADHD often find this difficult, however. They are ... a prompt but smaller reward instead of making a choice ...
(Date:8/21/2014)... 21, 2014 The ... Vascular Devices Market by Angioplasty Balloon ... (IVUS, OCT), IVC Filter (Retrievable), Endovascular ... analyzes and studies the major market ... U.S. and Canada. , Browse 108 ...
Breaking Medicine News(10 mins):Health News:Relias Learning Announces Support for Tin Can API 2Health News:ERT Opens Registration for PROFICIENCY™ Regional Conference Series 2Health News:ERT Opens Registration for PROFICIENCY™ Regional Conference Series 3Health News:ADHD children make poor decisions due to less differentiated learning processes 2Health News:North American Interventional Cardiology and Peripheral Vascular Devices Market worth $5.9 Billion by 2018 - Research Report by MarketsandMarkets 2Health News:North American Interventional Cardiology and Peripheral Vascular Devices Market worth $5.9 Billion by 2018 - Research Report by MarketsandMarkets 3Health News:North American Interventional Cardiology and Peripheral Vascular Devices Market worth $5.9 Billion by 2018 - Research Report by MarketsandMarkets 4Health News:North American Interventional Cardiology and Peripheral Vascular Devices Market worth $5.9 Billion by 2018 - Research Report by MarketsandMarkets 5
Other Contents